Literature DB >> 6342758

Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.

M J Kornstein, J S Brooks, D E Elder.   

Abstract

Using an avidin:biotin immunoperoxidase system with monoclonal antibodies to lymphocyte subsets, we have investigated the host response to malignant melanoma and melanocytic nevi in frozen sections. Eight primary melanomas, eight metastases, three dysplastic nevi, and two dermal nevi were studied with antibodies T11, T4, T8, and B1. Sections were read in a semiquantitative manner by two observers. Virtually all lymphocytes in these lesions were T-cells (T11 positive). In all primary melanomas, in the majority of metastases, and in all dysplastic nevi, both T4- and T8-positive cells were present. In two of eight metastases, tumor cells stained with T4, and in one case, melanoma cells stained with B1 antibody. The host response to melanoma involves primarily T-cells and includes both the helper:inducer (T4) and suppressor:cytotoxic (T8) subsets.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342758

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  The significance of inflammation and regression in melanoma.

Authors:  M G Cook
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease.

Authors:  D H Rubin; M J Kornstein; A O Anderson
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Monocytes and other infiltrating cells in human colorectal tumours identified by monoclonal antibodies.

Authors:  C Allen; N Hogg
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

Review 4.  Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

Authors:  W H Cole; L Humphrey
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

5.  DNA content and MHC class II antigen expression in malignant melanoma: clinical course.

Authors:  J Zaloudik; M Moore; A K Ghosh; Z Mechl; A Rejthar
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

6.  Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.

Authors:  M R Hussein; D A H Elsers; S A Fadel; A-E M Omar
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

7.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.

Authors:  D Guerry; M A Alexander; M F Herlyn; L M Zehngebot; K F Mitchell; C M Zmijewski; E J Lusk
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Identification of lymphocyte subsets and natural killer cells in head and neck cancers. An immunohistological study using monoclonal antibodies.

Authors:  Y Harabuchi; N Yamanaka; A Kataura
Journal:  Arch Otorhinolaryngol       Date:  1985

Review 9.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  Macrophages in melanocytic naevi.

Authors:  E B Bröcker; C Reckenfeld; H Hamm; D J Ruiter; C Sorg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.